These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8280698)

  • 41. Malignant melanoma of conjunctiva.
    Mathur GB; Kothari RS; Mangal HN; Charan H
    Indian J Ophthalmol; 1971 Mar; 19(1):34-7. PubMed ID: 15744963
    [No Abstract]   [Full Text] [Related]  

  • 42. Conjunctival melanoma arising from primary acquired melanosis in a patient with neurofibromatosis type I.
    Stacy RC; Kenyon KR; Jakobiec FA; Colby KA
    Cornea; 2010 Feb; 29(2):232-4. PubMed ID: 20023582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conjunctival pigmented epithelioid melanocytoma: a clinicopathological case report.
    Bissig A; Moulin A; Spahn B; Zembowicz A; Schalenbourg A
    Arch Ophthalmol; 2012 Nov; 130(11):1478-9. PubMed ID: 23143456
    [No Abstract]   [Full Text] [Related]  

  • 44. Desmoplastic melanoma of the eyelid and conjunctival melanoma in neurofibromatosis type 1: a clinical pathological correlation.
    Rubinstein TJ; Plesec TP; Singh AD
    Surv Ophthalmol; 2015; 60(1):72-7. PubMed ID: 25233828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topical mitomycin chemotherapy for malignant conjunctival and corneal neoplasia.
    Finger PT
    Br J Ophthalmol; 2006 Jul; 90(7):807-9. PubMed ID: 16782942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Malignant melanoma of the conjunctiva--clinical course and histopathologic findings].
    Stefani FH
    Fortschr Ophthalmol; 1986; 83(1):141-5. PubMed ID: 3710347
    [No Abstract]   [Full Text] [Related]  

  • 47. Conjunctival melanoma.
    McGhee CN; Ni C; Albert DM; Chu FR
    Int Ophthalmol Clin; 1982; 22(3):35-56. PubMed ID: 7107132
    [No Abstract]   [Full Text] [Related]  

  • 48. Malignant melanoma of conjunctiva following surgical excision of naevus.
    Betharia SM; Vashisht S; Kalra BR
    Indian J Ophthalmol; 1985; 33(4):259-61. PubMed ID: 3842836
    [No Abstract]   [Full Text] [Related]  

  • 49. Conjunctival metastasis from a cutaneous melanoma as the initial sign of dissemination.
    Kwapiszeski BR; Savitt ML
    Am J Ophthalmol; 1997 Feb; 123(2):266-8. PubMed ID: 9186141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-term mitomycin C followed by long-term interferon alpha2beta for conjunctiva-cornea intraepithelial neoplasia.
    Huerva V; Mateo AJ; Mangues I; Jurjo C
    Cornea; 2006 Dec; 25(10):1220-3. PubMed ID: 17172902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical chemotherapy for ocular surface squamous neoplasia.
    Nanji AA; Sayyad FE; Karp CL
    Curr Opin Ophthalmol; 2013 Jul; 24(4):336-42. PubMed ID: 23680759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of combination therapy of topical mitomycin C and cyclosporine a as an adjunct to surgery for corneal and conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma.
    Sugandhi P; George RE
    Cornea; 2011 Apr; 30(4):486; author reply 486-7. PubMed ID: 21107255
    [No Abstract]   [Full Text] [Related]  

  • 54. Conjunctival Melanoma Responsive to Combined Systemic BRAF/MEK Inhibitors.
    Dagi Glass LR; Lawrence DP; Jakobiec FA; Freitag SK
    Ophthalmic Plast Reconstr Surg; 2017; 33(5):e114-e116. PubMed ID: 27893585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impression cytology of conjunctival melanosis and melanoma.
    Paridaens AD; McCartney AC; Curling OM; Lyons CJ; Hungerford JL
    Br J Ophthalmol; 1992 Apr; 76(4):198-201. PubMed ID: 1390485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Malignant melanoma on primary acquired conjunctival melanosis].
    Meyer A; D'Hermies F; Schwartz L; Morel X; Elmaleh C; Renard G
    J Fr Ophtalmol; 1999 Nov; 22(9):983-6. PubMed ID: 10609177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiation of pigmented conjunctival squamous cell carcinoma from melanoma.
    Shields JA; Shields CL; Luminais S; Eagle RC
    Ophthalmic Surg Lasers Imaging; 2003; 34(5):406-8. PubMed ID: 14509468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemosensitivity of conjunctival melanoma cell lines to single chemotherapeutic agents and combinations.
    Westekemper H; Freistuehler M; Anastassiou G; Nareyeck G; Bornfeld N; Steuhl KP; Scheulen ME; Hilger RA
    Br J Ophthalmol; 2012 Apr; 96(4):591-6. PubMed ID: 22275346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Periocular allergic contact dermatitis following topical Mitomycin C eye drop application.
    Cumurcu T; Sener S; Cavdar M
    Cutan Ocul Toxicol; 2011 Sep; 30(3):239-40. PubMed ID: 21309691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
    Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
    Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.